Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

A new study used in silico approaches for designing a next-generation CD40-targeting vaccine, CD40.

Related Keywords

China ,Hubei ,Guangdong ,Wuhan ,Lunla Shutterstock , ,Image Credit ,Middle East ,Proteina Affinity ,T Andb Cell ,Cell ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Vaccine ,Ce2 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Antibodies ,Ntigen ,Flood ,D4 ,Coronavirus ,Iagnostic ,Efficacy ,Nzyme ,Homologous ,Immune Response ,Ers Cov ,Pandemic ,Reclinical ,Protein ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,T Cell ,